Portal de Periódicos da CAPES

Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine

2021; Oxford University Press; Volume: 186; Issue: 3 Linguagem: Inglês

10.1111/bjd.20876

1365-2133

Tina Žagar, Nika Hlača, Ines Brajac, Larisa Prpić Massari, Sandra Peternel, Marija Kaštelan,

Tumors and Oncological Cases

Journal Article Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine Get access T. Žagar, T. Žagar Department of Dermatovenereology Clinical Hospital Centre Rijeka Rijeka Croatia Search for other works by this author on: Oxford Academic Google Scholar N. Hlača, N. Hlača Department of Dermatovenereology Clinical Hospital Centre Rijeka Rijeka CroatiaFaculty of Medicine University of Rijeka Rijeka Croatia Correspondence: Nika Hlača. Email: nika.hlaca@uniri.hr https://orcid.org/0000-0002-0517-5462 Search for other works by this author on: Oxford Academic Google Scholar I. Brajac, I. Brajac Department of Dermatovenereology Clinical Hospital Centre Rijeka Rijeka CroatiaFaculty of Medicine University of Rijeka Rijeka Croatia Search for other works by this author on: Oxford Academic Google Scholar L. Prpić‐Massari, L. Prpić‐Massari Department of Dermatovenereology Clinical Hospital Centre Rijeka Rijeka CroatiaFaculty of Medicine University of Rijeka Rijeka Croatia Search for other works by this author on: Oxford Academic Google Scholar S. Peternel, S. Peternel Department of Dermatovenereology Clinical Hospital Centre Rijeka Rijeka CroatiaFaculty of Medicine University of Rijeka Rijeka Croatia https://orcid.org/0000-0001-8590-0451 Search for other works by this author on: Oxford Academic Google Scholar M. Kaštelan M. Kaštelan Department of Dermatovenereology Clinical Hospital Centre Rijeka Rijeka CroatiaFaculty of Medicine University of Rijeka Rijeka Croatia Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 186, Issue 3, 1 March 2022, Page e110, https://doi.org/10.1111/bjd.20876 Published: 01 March 2022